| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.4M | -21.1% |
| SG&A Expense | $9.6M | -5.4% |
| Operating Income | -$25.5M | +6.3% |
| Interest Expense | $70K | -27.7% |
| Pre-tax Income | -$23.6M | +18.5% |
| Net Income | -$23.6M | +18.5% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | -87.2% |
| Short-term Investments | $60.6M | — |
| Current Assets | $78.9M | -28.1% |
| Total Assets | $88.0M | -20.2% |
| Current Liabilities | $7.4M | +30.9% |
| Total Liabilities | $7.9M | -6.3% |
| Stockholders' Equity | $80.1M | -21.3% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.2M | +9.9% |
| Investing Cash Flow | -$72.5M | — |
| Financing Cash Flow | $6K | -100.0% |